I-Med Technology Secures Investment to Enhance 3D Medical Imaging
Netherlands, Friday, 27 December 2024.
I-Med Technology has received significant funding from 819 Capital Partners and LIOF to advance their head-mounted 3D imaging systems, aiming to improve precision in medical and dental procedures.
Strategic Investment for Healthcare Innovation
I-Med Technology B.V., headquartered at the Brightlands Health Campus in Maastricht, secured this strategic investment in November 2024 [1]. The company, which was founded in 2018 [1], is positioning itself at the forefront of the rapidly expanding medical imaging market, which is projected to reach USD 35.0 billion by 2026 [2]. This healthtech innovation comes at a crucial time when digital technologies are transforming medical visualization capabilities, particularly in surgical and dental applications [1][2].
Revolutionary 3D Imaging Technology
The company’s Digital Head-mounted Microscope represents a significant advancement in medical imaging technology, offering Full HD real-time 3D imaging with mixed reality capabilities [1]. According to Vincent Graham, CTO at I-Med, this technology addresses a critical challenge in traditional 2D imaging systems where clinicians must frequently shift their focus away from the surgical field [1]. The system’s integration of AR/VR technologies enhances both precision and efficiency, particularly important as these technologies are increasingly being adopted in medical procedures for improved patient care [2].
Training and AI Integration
Beyond its immediate surgical applications, the system offers substantial benefits for medical training and education. As highlighted by CCO Jaap Heukelom, the platform provides powerful capabilities for remote support and artificial intelligence integration [1]. This aligns with broader industry trends, as the AI in medical diagnostics market is expected to reach USD 3,868 million by 2025 [2], demonstrating the growing importance of intelligent imaging solutions in healthcare.
Investment Impact and Future Prospects
The investment comes from 819 Capital Partners’ Evergreen Fund I, focused on deep-tech and med-tech ventures, and LIOF’s Participation Fund, which supports innovative SMEs [1]. Willem van Esch from LIOF emphasizes that this investment will help make advanced imaging more accessible across the healthcare sector [1]. With the global holographic display market, a key component of advanced medical imaging, projected to reach USD 17.71 billion by 2032 [3], I-Med Technology is well-positioned to capitalize on this growing market opportunity.